Microdosing Psychedelics: Efficacy and Safety Review

Microdosing Psychedelics: A New Review

A recent systematic review and meta-analysis has assessed the efficacy and safety of psychedelic microdosing on psychological outcomes in healthy adults. This comprehensive study, published on August 13, 2026, in OpenAlex, aims to clarify ongoing debates about the practice's benefits and risks. Despite its thoroughness, the review has not yet gained significant traction within the academic community, as indicated by its lack of citations.

Mechanisms and Context of Microdosing

Psychedelic microdosing involves the regular intake of sub-perceptual doses of substances like LSD (lysergic acid diethylamide) or psilocybin. Proponents claim it can enhance mood, creativity, and cognitive function without the intense experiences associated with full doses. This review synthesizes data from various studies to evaluate these claims, focusing on psychological outcomes such as anxiety, depression, and overall well-being.

Implications for Clinical Practice and Research

The findings from this review could significantly influence clinical practices and future research directions. By providing a clearer picture of microdosing's effects, the study offers a foundation for developing guidelines and protocols for its use in therapeutic settings. Additionally, it highlights areas where further research is needed, particularly in understanding long-term effects and the mechanisms underlying observed psychological changes.

Risks and Unknowns in Microdosing

While the review presents potential benefits, it also underscores several risks and unknowns associated with psychedelic microdosing. These include the possibility of adverse psychological effects, variability in individual responses, and the lack of standardized dosing protocols. The review calls for more rigorous, controlled studies to better assess these risks and to establish safe, effective microdosing practices.

Future Directions in Psychedelic Research

Looking forward, the review suggests that future research should focus on larger, well-controlled trials to further explore microdosing's efficacy and safety. It also emphasizes the need for interdisciplinary approaches, integrating insights from neuroscience, psychology, and pharmacology to develop a comprehensive understanding of microdosing's impact. As the field evolves, these efforts could lead to more informed policy decisions and clinical applications.